PharmaEssentia Corporation (6446.TW)

TWD 572.0

(-1.38%)

Operating Income Summary of PharmaEssentia Corporation

  • PharmaEssentia Corporation's latest annual operating income in 2023 was - TWD , up 48.43% from previous year.
  • PharmaEssentia Corporation's latest quarterly operating income in 2024 Q2 was 932.71 Million TWD , up 30.27% from previous quarter.
  • PharmaEssentia Corporation reported an annual operating income of -1.82 Billion TWD in 2022, up 34.9% from previous year.
  • PharmaEssentia Corporation reported an annual operating income of -2.8 Billion TWD in 2021, down -44.4% from previous year.
  • PharmaEssentia Corporation reported a quarterly operating income of 932.71 Million TWD for 2024 Q2, up 30.27% from previous quarter.
  • PharmaEssentia Corporation reported a quarterly operating income of -185.45 Million TWD for 2023 Q2, up 74.97% from previous quarter.

Annual Operating Income Chart of PharmaEssentia Corporation (2023 - 2019)

Historical Annual Operating Income of PharmaEssentia Corporation (2023 - 2019)

Year Operating Income Operating Income Growth
2023 - TWD 48.43%
2022 -1.82 Billion TWD 34.9%
2021 -2.8 Billion TWD -44.4%
2020 -1.93 Billion TWD -128.42%
2019 -849.22 Million TWD 0.0%

Peer Operating Income Comparison of PharmaEssentia Corporation

Name Operating Income Operating Income Difference
Grape King Bio Ltd 2.49 Billion TWD 100.0%
Standard Chem & Pharm CO., LTD. 1.25 Billion TWD 100.0%
Maywufa Company Ltd. 211.01 Million TWD 100.0%
ScinoPharm Taiwan, Ltd. 314.49 Million TWD 100.0%
Lotus Pharmaceutical Co., Ltd. 4.9 Billion TWD 100.0%
LIWANLI Innovation Co., Ltd. - TWD NaN%
YungShin Global Holding Corporation 929.61 Million TWD 100.0%
PhytoHealth Corporation -121.67 Million TWD 100.0%
SCI Pharmtech, Inc. 160.3 Million TWD 100.0%
Formosa Laboratories, Inc. 674.97 Million TWD 100.0%
Bora Pharmaceuticals Co., LTD. 5.24 Billion TWD 100.0%